| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Leen Ann M. is a Chief Scientific Officer at Kalaris Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 22 sells.
Estimated insider holdings value: $546K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2021 | KLRS Kalaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 20,988 | $22.18 | $465,559.20 | -0.2% | -60.1% | -64.7% | |
| May 10, 2021 | KLRS Kalaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 150,000 | $22.75 | $3,412,500.00 | -6.1% | -2.7% | -82.9% | |
| Mar 16, 2021 | KLRS Kalaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,025 | $30.00 | $90,750.91 | -0.1% | -20.9% | -72.0% | |
| Mar 1, 2021 | KLRS Kalaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 9,518 | $38.70 | $368,329.21 | -0.2% | - | - | |
| Feb 23, 2021 | KLRS Kalaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 17,446 | $41.48 | $723,624.58 | -0.1% | - | - | |
| Feb 18, 2021 | KLRS Kalaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 2,700 | $40.81 | $110,194.24 | - | - | - | |
| Feb 17, 2021 | KLRS Kalaris Therapeutics, Inc. | Chief Scientific Officer | Sell | 5,336 | $41.27 | $220,200.62 | - | - | - |